Kubouchi et al. and Yurugi et al. focused on podoplanin (PDPN), a CAF marker, and reported that overexpression of PDPN in CAF has a negative prognostic impact in NSCLC.10, 11. This evidence concerns the gene PDPN and non-small cell lung carcinoma.